ConductScience.org, home

Paper17560554

Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin.

Duncan RS and 8 others. Biochem Pharmacol, 2007. Cited by 43 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin. Papers, record 17560554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17560554

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin.
PubMed
Journal
Biochem Pharmacol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2018-11-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Duncan RSR S
2McPate MJM J
3Ridley JMJ M
4Gao ZZ
5James AFA F
6Leishman DJD J
7Leaney JLJ L
8Witchel HJH J
9Hancox JCJ C

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive Agents, TricyclicMajor topic
DoxepinMajor topic
Ether-A-Go-Go Potassium ChannelsMajor topic
Animals
Cells, Cultured
ERG1 Potassium Channel
Heart Ventricles
Patch-Clamp Techniques
Rabbits

Source PubMed

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19,486,667Molecular determinants of dofetilide block of HERG K+ channels.Circ Res1998https://conductscience.org/library/papers/9486667PubMed
29,449,325Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.Biophys J1998https://conductscience.org/library/papers/9449325PubMed
39,679,158Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.J Physiol1998https://conductscience.org/library/papers/9679158PubMed
410,219,239MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.Cell1999https://conductscience.org/library/papers/10219239PubMed
510,510,461Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.Br J Pharmacol1999https://conductscience.org/library/papers/10510461PubMed
615,541,373High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.Biochem Biophys Res Commun2004https://conductscience.org/library/papers/15541373PubMed
715,673,388Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG.J Cardiovasc Electrophysiol2005https://conductscience.org/library/papers/15673388PubMed
815,691,222Drugs, QT interval prolongation and ICH E14: the need to get it right.Drug Saf2005https://conductscience.org/library/papers/15691222PubMed
915,749,156Predicting drug-hERG channel interactions that cause acquired long QT syndrome.Trends Pharmacol Sci2005https://conductscience.org/library/papers/15749156PubMed
1016,011,830The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C.Biochem Biophys Res Commun2005https://conductscience.org/library/papers/16011830PubMed
1116,039,272Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.Cardiovasc Res2005https://conductscience.org/library/papers/16039272PubMed
1216,144,878QT prolongation and syncope with methadone, doxepin, and a beta-blocker.Ann Pharmacother2005https://conductscience.org/library/papers/16144878PubMed
1316,301,704Short QT syndrome.CMAJ2005https://conductscience.org/library/papers/16301704PubMed
1416,288,909Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.J Mol Cell Cardiol2006https://conductscience.org/library/papers/16288909PubMed
1516,446,155Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652.Biochem Biophys Res Commun2006https://conductscience.org/library/papers/16446155PubMed
1616,423,345Inhibition of cardiac HERG potassium channels by antidepressant maprotiline.Eur J Pharmacol2006https://conductscience.org/library/papers/16423345PubMed
1716,554,806hERG potassium channels and cardiac arrhythmia.Nature2006https://conductscience.org/library/papers/16554806PubMed
1816,542,653Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656.FEBS Lett2006https://conductscience.org/library/papers/16542653PubMed
1916,474,415Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin.Br J Pharmacol2006https://conductscience.org/library/papers/16474415PubMed
2016,736,158Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.Naunyn Schmiedebergs Arch Pharmacol2006https://conductscience.org/library/papers/16736158PubMed

See all 63 references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
37,195,310Precision Medicine in Antidepressants Treatment.Handb Exp Pharmacol2023https://conductscience.org/library/papers/37195310PubMed
36,142,644New Insights into Ion Channels: Predicting hERG-Drug Interactions.Int J Mol Sci2022https://conductscience.org/library/papers/36142644PubMed
35,560,982Inhibition of TRPC4 channel activity in colonic myocytes by tricyclic antidepressants disrupts colonic motility causing constipation.J Cell Mol Med2022https://conductscience.org/library/papers/35560982PubMed
32,252,558Drug-specific risk of severe QT prolongation following acute drug overdose.Clin Toxicol (Phila)2020https://conductscience.org/library/papers/32252558PubMed
28,814,790In silico investigation of a KCNQ1 mutation associated with short QT syndrome.Sci Rep2017https://conductscience.org/library/papers/28814790PubMed
28,592,292Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.Biomed Eng Online2017https://conductscience.org/library/papers/28592292PubMed
27,891,211From linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporter.Medchemcomm2016https://conductscience.org/library/papers/27891211PubMed
24,877,995Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutants.J Mol Cell Cardiol2014https://conductscience.org/library/papers/24877995PubMed
21,777,565The hERG K(+) channel S4 domain L532P mutation: characterization at 37°C.Biochim Biophys Acta2011https://conductscience.org/library/papers/21777565PubMed
21,660,488Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.J Mol Model2012https://conductscience.org/library/papers/21660488PubMed
20,229,012Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine.Naunyn Schmiedebergs Arch Pharmacol2010https://conductscience.org/library/papers/20229012PubMed
20,150,828KCNH2 pharmacogenomics summary.Pharmacogenet Genomics2010https://conductscience.org/library/papers/20150828PubMed
19,916,999Sudden death in patients receiving drugs tending to prolong the QT interval.Br J Clin Pharmacol2009https://conductscience.org/library/papers/19916999PubMed
19,720,020Transfer of rolf S3-S4 linker to HERG eliminates activation gating but spares inactivation.Biophys J2009https://conductscience.org/library/papers/19720020PubMed
18,724,381Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.Br J Pharmacol2008https://conductscience.org/library/papers/18724381PubMed
18,542,937Impaired heart rate variability and altered cardiac sympathovagal balance after antidepressant overdose.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18542937PubMed
18,458,880Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.Naunyn Schmiedebergs Arch Pharmacol2008https://conductscience.org/library/papers/18458880PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERG2,078PubTator's text mininghttps://conductscience.org/library/genes/2078NCBI Gene
KCNE29,992PubTator's text mininghttps://conductscience.org/library/genes/9992NCBI Gene
KCNH23,757PubTator's text mininghttps://conductscience.org/library/genes/3757NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17560554

GET https://conductscience.org/api/papers/v1/17560554/references?page=2